Observational analysis found RGS2 suppresses S1P2 and S1P3 signaling, indicating a role in colon cancer progression.
Sphingosine-1-phosphate receptor 2 (S1P2) and S1P3 are G protein-coupled receptors that mediate extracellular sphingosine-1-phosphate (S1P) signaling into cells. S1P2 and S1P3 are highly expressed in colon cancer cells, but their roles in cancer progression-related cellular phenotypes are not well understood. Recent studies suggest that RGS2 interacts with GPCRs, either directly or indirectly, to regulate their signaling. However, the precise role of RGS2 in S1P2 and S1P3 signaling remains uninvestigated. In this study, we examined the interaction of RGS2 with S1P2 and S1P3 using BRET analysis and assessed its impact on S1P2- and S1P3-mediated signaling in 293T and HCT116 cells. BRET analysis revealed that RGS2 and Gα subunits simultaneously bind to S1P2 and S1P3. Furthermore, in the presence of these receptors, RGS2 translocated from the cytoplasm to the cell membrane. These interactions and membrane translocation were not observed with the RGS1 negative control, highlighting the specificity of RGS2 for S1P2 and S1P3. RGS2 expression inhibited the activation of Gαi, Gαq, and Gα12, key signaling pathways mediated by S1P2 and S1P3. S1P2 and S1P3 activation significantly enhanced cell migration and the expression of cancer-associated genes, effects that were effectively suppressed by RGS2 expression. In contrast, RGS1 failed to inhibit S1P2- and S1P3-mediated Gα signaling, as well as downstream effects such as enhanced cell migration and cancer-associated gene expression. Our findings show that RGS2 suppresses S1P2- and S1P3-mediated cancer-associated cellular phenotypes by interacting with these receptors and inhibiting Gα-mediated signaling.
No takes yet. Share an insight, caveat, or question.
Eo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: